OMX Ventures
Overview
OMX Ventures is a life sciences venture capital firm that specializes in early-stage investments at the intersection of biology, big data, and artificial intelligence, focusing on therapeutics, bio-tools, diagnostics, and synthetic biology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Stipple Bio | Dec 2024 | Seed | Co-investor |
| Delix Therapeutics | Sep 2021 | Series A | Lead |
| Lightcast Discovery | Apr 2026 | VC Round | Co-investor |
| Fynch Biosciences | Sep 2020 | Series D | Co-investor |
| Ensocell | May 2024 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is OMX Ventures based?
OMX Ventures is headquartered in Lincolnshire, Illinois, United States.
When was OMX Ventures founded?
OMX Ventures was founded in 2020.
How many portfolio companies does OMX Ventures have?
OMX Ventures has 10 portfolio companies in Caplight's dataset.
What are some companies in OMX Ventures's portfolio?
Portfolio companies visible on Caplight include Stipple Bio, Delix Therapeutics, Lightcast Discovery, Fynch Biosciences, Ensocell.
What was OMX Ventures's most recent investment shown here?
OMX Ventures's most recent investment in this portfolio sample was in Lightcast Discovery in 2026.
What sectors does OMX Ventures focus on?
OMX Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does OMX Ventures focus on?
OMX Ventures typically invests at the Early stage.
What is OMX Ventures's AUM?
OMX Ventures's assets under management are estimated between $150.0M and $245.0M.